COVID-19 and intestinal inflammation: Role of fecal calprotectin
Authors:
- Veronica OjettiVOVeronica Ojetti
- Angela SavianoASAngela Saviano
- Marcello CovinoMarcello Covino
- Nicola AcamporaNANicola Acampora
- Eliana TroianiETEliana Troiani
- Francesco FranceschiFFFrancesco Franceschi
- Valeria AbbateVAValeria Abbate
- 1 November 2020
- journal article
- letter
- Published by Elsevier in Digestive and Liver Disease
- Vol. 52 (11) , 1231-1233
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and ManagementClinical Gastroenterology and Hepatology, 2020
- COVID-19: Gastrointestinal Manifestations and Potential Fecal–Oral TransmissionGastroenterology, 2020
- Covid‐19 and the digestive systemJournal of Gastroenterology and Hepatology, 2020
- Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cellsProceedings of the National Academy of Sciences, 2020
- The Novel Coronavirus (SARS-CoV-2) PandemicAnnals of the Academy of Medicine, Singapore, 2020
- The Cross-Talk Between Gut Microbiota and Lungs in Common Lung DiseasesFrontiers in Microbiology, 2020
- A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)Military Medical Research, 2020
- Fecal Calprotectin2018
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathologySeminars in Immunopathology, 2017